Informational Alert

Test QA informational alert

Menu
Open Search

Controlled Substance Schedule 

The list of controlled substances posted on the DHEC website is for informational purposes only. The posted list includes all substances scheduled in accordance with the provisions of SC Code Section 44-53-160, designated by the DHEC Board and transmitted to the General Assembly since the last SC Code update in 2012, as well as the list of scheduled substances currently in the SC Code for Schedules I-V. Please review the Board Orders posted on this page, as well as the Federal Register, for detailed information on the scheduling actions of controlled substances.

DrugCommon NameScheduleDate of DPS ScheduleBoard OrdersCode Section
1-(2-methyl-4-4(3- phenylprop-2-en-l-yl)piperazin-1-yl)butan-1-one2-methyl AP-237C-I4/11/2024Board Order44-53-190
Methyl 2-(1-(4-fluorobenzyl)-lH-indole-3- carboxamido)-3-methyl butanoateMMB-FUBICAC-I01/04/2024Board Order44-53-190
Ethyl 2-[[1-(5-fluoropentyl)indole-3-carbonyl]amino ]-3,3-dimethyl-butanoate5F-EDMB-PICAC-I01/04/2024Board Order44-53-190
5-Pentyl-2-(2-phenylpropan-2-yl)pyrido[ 4,3-b ]indol-1-oneCUMYL-­PEGACLONEC-I01/04/2024Board Order44-53-190
-(l­amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(pent-4-en-l-yl)-lH-indazole-3-carboxamideADB- 4en-PINACAC-I01/04/2024Board Order44-53-190
Methyl 2-[[1-( 4-fluorobutyl)indole-3- carbonyl]amino]-3,3-dimethyl-butanoate4F-MDMB-BUTICAC-I01/04/2024Board Order44-53-190
Methyl 3,3-dimethyl-2-(1-(pent-4-en-1-yl)-lH-indazole-3- carboxamido )butanoateMDMB-4en-PINACAC-I01/04/2024Board Order44-53-190
N-(3-fluorophenyl)-N-(1- phenethylpiperidin-4-yl)propionamideMeta­-fluorofentanylC-I01/04/2024Board Order44-53-190
N-(3-fluorophenyl)-N-( l­phenethylpiperidin-4-yl)isobutyramide Meta-fluoroisobutyryl fentanylC-I01/04/2024Board Order44-53-190
N-(4-methoxyphenyl)-N-(l­phenethylpiperidin-4-yl)furan-2-carboxamide Para-methoxyfuranyl fentanylC-I01/04/2024Board Order44-53-190
N-(l-phenethylpiperidin-4-yl)-N­phenylfuran-3-carboxamide )3-furanyl fentanylC-I01/04/2024Board Order44-53-190
N-( 1-(2,5-dimethoxyphenethy l)piperidin-4-y 1)-N­phenylpropionamide 2 ',5 '-dimethoxyfentanyl C-I01/04/2024Board Order44-53-190
3-methyl-N-(l-phenethylpiperidin-4-yl)-N-phenylbutanamideIsovaleryl fentanylC-I01/04/2024Board Order44-53-190
N-(2-fluorophenyl)-N-(l -phenethylpiperidin-4-y l)furan-2-carboxamide Ortho-fluorofuranyl fentanylC-I01/04/2024Board Order44-53-190
2-methyl-N-( l-phenethylpiperidin-4-yl)-N-phenylbutanamide Alpha'-methyl butyryl fentanylC-I01/04/2024Board Order44-53-190
N-( 4-methylphenyl)-N-(l-phenethylpiperidin-4- yl)cyclopropanecarboxamidePara-­methylcyclopropyl fentanylC-I01/04/2024Board Order44-53-190
 1- [2-[(3R,5R,8R,9R,10S,13S,14S,17S)-3- hydroxy-3,13-dimethyl-2,4,5,6,7,8,9,10,11,12,14,15,16,17- tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2- oxoethyl]pyrazole-4-carbonitrileZuranoloneC-IV11/9/2023Board Order44-53-250
7-chloro-5-(2-chlorophenyl)-1-methyl-1,3-dihydro-2Hbenzo[e][1,4]diazepin-2-oneDiclazepamC-I08/10/2023Board Order44-53-190
8-bromo-6-(2-fluorophenyl)-1-methyl-4H-benzo[f][1,2,4]triazolo[4,3-1][1,4]diazepine (alternate chemical name: 8-bromo-6-(2-flurophenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepineFlubromazolamC-I08/10/2023Board Order44-53-190
6-(2-chlorophenyl)-1-methyl-8-nitro-4H-benzo[f][1,2,4]triazolo[4,3-1][1,4]diazepineClonazolamC-I08/10/2023Board Order44-53-190
8-chloro-6-(2-fluorophenyl)-1-methyl-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepineFlualprazolamC-I08/10/2023Board Order44-53-190
4-(2-chlorophenyl-2-ethyl-9- methyl-6H-thieno[3,2-f][1, 2, 4] triazolo[4,3-a][1,4]diazepineEtizolamC-I08/10/2023Board Order44-53-190
N-ethyl-α-methyl-3-(trifluoromethyl)phenethylamineFenfluramineC-IV01/05/2023Board Order43-53-250
N-methyl-1-(thiophen-2-yl)propan-2-amineMethiopropamineC-I01/05/2023Board Order44-53-190
N-phenyl-N' -(3-(1 - phenylpropan-2-yl)-1, 2, 3-oxadiazol-3- ium-5-yl) carbamimidate)MesocarbC-I12/08/2022Board Order44-53-190
7-[(10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-yl)amino]heptanoic acid)AmineptineC-I12/08/2022Board Order44-53-190
1-methoxy-3-[4-(2- methoxy-2-phenylethyl)piperazin-1-yl]- 1-phenylpropan-2-ol)ZipeprolC-I12/08/2022Board Order44-53-190
2-(ethylamino)-2-(3-methoxyphenyl)cyclohexan-1-oneMethoxetamineC-I06/29/2022Board Order44-53-190
[(3􀄮-hydroxy-3􀈕-methyl-5􀄮-pregnan-20-one)GanaxoloneC-V06/29/2022Board Order44-53-270
N,N-diethyl-2-(5-nitro-2-( 4-propoxybenzyl)-lH-benzimidazol-l-yl)ethan-1- amineProtonitazeneC-I05/05/2022Board Order44-53-190(B)
2-( 4-ethoxybenzyl)-5-nitro-1-(2-(pyrrolidin-1-yl)ethyl)-lH-benzimidazoleN-Pyrrolidino etonitazeneC-I05/05/2022Board Order44-53-190(B)

N,N-diethyl-2-(2-( 4-methoxybenzyl)-5-nitro-lH-benzimidazol-1-yl)ethan-l- amine

Metonitazene

C-I05/05/2022Board Order44-53-190(B)
N,N-diethyl-2-(2-(4-methoxybenzyl)-lH­benzimidazol-1-yl)ethan-1-amineMetodesnitazeneC-I05/05/2022Board Order44-53-190(B)

N,N-diethyl-2-(2-(4-fluorobenzyl)-5-nitro-lH-benzimidazol-1-yl)ethan-1- amine

FlunitazeneC-I05/05/2022Board Order44-53-190(B)

2-(2-( 4-ethoxybenzyl)-lH-benzimidazol-1-yl)-N,N-diethylethan-1-amine

EtodesnitazeneC-I05/05/2022Board Order44-53-190(B)
2-(2-(4-butoxybenzyl)-5-nitro-IH-benzimidazol-l-yl)-N,N­diethylethan-l- amine

Butonitazene

C-I05/05/2022Board Order44-53-190(B)
4,4′-Dimethylaminorex; 4,5-dihydro-4-methyl-5-(4-methylphenyl)-2-oxazolamine; 4-methyl-5-(4- methylphenyl)-4,5-dihydro-1,3-oxazol-2-amine4,4′-DMARC-I09/09/2021Board Order44-53-19
methamphetaminepara-Methoxymethamphetamine (PMMA)C-I07/15/2021Board Order44-53-190(D)
methyl 2-(1- (4-fluorobutyl)-1H-indazole-3- carboxamido)-3,3-dimethylbutanoate4F–MDMB–BUTINACAC-I07/15/2021Board Order44-53-190(D)
3-[[[(1S)-1-carboxy-2-hydroxyethyl]- amino]carbonyl]-1-[[[[(2R)-2-[(1R)-2-methoxy-2-oxo-1-phenylethyl]-1- piperidinyl]carbonyl]oxy]methyl]pyridinium chlorideSerdexmethylphenidateC-IV05/13/2021Board Order44-53-250
Ethyl (1-phenethylpiperidin-4- yl)(phenyl)carbamate (fentanyl carbamate)Fentanyl CarbamateC-105/13/2021Board Order44-53-190(B)
N-(2-fluorophenyl)-N-(1- phenethylpiperidin-4-yl)acrylamide (ortho-fluoroacryl fentanyl)Ortho-fluoroacryl FentanylC-105/13/2021Board Order44-53-190(B)
N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide (ortho-fluoroisobutyryl fentanyl)Ortho-fluoro Isobutyryl FentanylC-105/13/2021Board Order44-53-190(B)
N-(4-fluorophenyl)-N-(1- phenethylpiperidin-4-yl)furan-2-carboxamide (para-fluoro furanyl fentanyl)Para-fluoro Furanyl FentanylC-105/13/2021Board Order44-53-190(B)
N-(1-(2-fluorophenethyl)piperidin-4-yl)-N-(2-fluorophenyl)propionamide        
(2′-fluoro ortho-fluorofentanyl; 2′-fluoro 2-fluorofentanyl		2′-Fluoro Ortho-fluorofentanylC-105/13/2021Board Order44-53-190(B)
N-(1-(4-methylphenethyl)piperidin-4-yl)-N-phenylacetamide (4′-methyl acetyl fentanyl)4′- methyl acetyl fentanylC-I05/13/2021Board Order44-53-190(B)
N-phenyl-N-(1-(2- phenylpropyl)piperidin-4- yl)propionamide (b-methyl fentanyl)b-methyl fentanylC-I05/13/2021Board Order44-53-190(B)
N-(2-fluorophenyl)-N-(1- phenethylpiperidin-4-yl)butyramide (ortho-fluorobutyryl fentanyl; 2-fluorobutyryl fentanyl)orthofluorobutyryl fentanylC-I05/13/2021Board Order44-53-190(B)
N-(2-methylphenyl)-N-(1- phenethylpiperidin-4-yl)acetamide (ortho-methyl acetylfentanyl; 2-methyl acetylfentanyl)ortho-methyl acetylfentanylC-I05/13/2021Board Order44-53-190(B)
2-methoxy-N-(2-methylphenyl)-N- (1-phenethylpiperidin-4-yl)acetamide (ortho-methylmethoxyacetylfentanyl; 2-methyl methoxyacetyl fentanyl)Ortho-methyl Methoxyacetyl FentanylC-I05/13/2021Board Order44-53-190(B)
N-(4-methylphenyl)-N-(1-phenethylpiperidin-4-yl)propionamide (para-methylfentanyl; 4- methylfentanyl)Paramethyl FentanylC-I05/13/2021Board Order44-53-190(B)
N-(1-phenethylpiperidin-4-yl)-N-phenylbenzamide (phenyl fentanyl; benzoyl fentanyl)Phenyl FentanylC-I05/13/2021Board Order44-53-190(B)
N-(1-phenethylpiperidin-4-yl)-N-phenylthiophene-2-carboxamide (thiofuranyl fentanyl; 2-thiofuranyl fentanyl; thiophene fentanyl)Thiofuranyl FentanylC-I05/13/2021Board Order44-53-190(B)
Oliceridine N-[(3- methoxythiophen-2-yl)methyl] ({2- [(9R)-9-(pyridin-2-yl)-6- oxaspiro [4.5]decan-9-yl]ethyl})amine fumarateOliceridineC-II11/12/2020Board Order44-53-210
Crotonyl fentanyl ((E)-N-(1-phenethylpiperidin-4-yl)-N-phenylbut-2-enamide)Crotonyl Fentanyl C-I10/08/2020Board Order44-53-190(B)
Remimazolam (4H-imidazol[1,2-a][1,4]benzodiazepine-4-propionic acid, 8-bromo-1-methyl-6-(2-pyridinyl)-(4S)- methyl ester, benzenesulfonate (1:1) or methyl 3-[(4S)-8-bromo-1-methyl-6- pyridin-2-yl-4H-imidazo[1,2-a][1,4]benzodiazepin-4yl]propanoate benzenesulfonic acid)RemimazolamC-IV10/08/2020Board Order44-53-250(A)
N,N-diethyl-2-(2-(4 isopropoxybenzyl)-5-nitro-1Hbenzimidazol-1-yl)ethan-1-amine, its isomers, esters, ethers, salts and salts of isomers, esters and ethers (Other names: isotonitazene; N,N-diethyl-2-[[4- (1-methylethoxy)phenyl]methyl]- 5-nitro-1H-benzimidazole-1- ethanamine)IsotonitazeneC-I9/10/2020Board Order44-53-190(B)
N-phenyl-N- (piperidin-4-yl)propionamide (norfentanyl)  NorfentanylC-II5/7/2020Board Order45-53-210
Cenobamate ([(1R)-1-(2-chlorophenyl)-2-(tetrazol-2-yl)ethyl] carbamate; 2H-tetrazole-2-ethanol, alpha-(2-chlorophenyl)-, carbamate (ester), (alphaR)-; carbamic acid (R)-(+)-1-(2-chlorophenyl)-2-(2H-tetrazol-2-yl)ethyl ester)   CenobamateC-V4/9/2020Board Order44-53-270
Lemborexant (1R,2S)-2-[(2,4-dimethylpyrimidin-5-yl)oxymethyl]-2-(3-fluorophenyl)-N-(5- fluoropyridin-2-yl)cyclopropane-1-carboxamideLemborexantC-IV4/9/2020Board Order44-53-250
Lasmiditan (2,4,6-trifluoro-N-(6-(1-methylpiperidine-4-carbonyl)pyridine-2-yl-benzamide) and its salts, isomers, and salts of isomers.LasmiditanC-V2/13/2020Board Order44-53-270
N-Ethylhexedrone, its optical, positional, and geometric isomers, salts and salts of isomers (Other name: 2-(ethylamino)-1-phenylhexan-1-one)N-EthylhexedroneC-I8/8/2019Board Order44-53-190(F)
alpha-Pyrrolidinohexanophenone, its optical, positional, and geometric isomers, salts and salts of isomers (Other names: α-PHP; alpha-pyrrolidinohexiophenone; 1-phenyl-2-(pyrrolidin-1-yl)hexan-1-one)α-PHPC-I8/8/2019Board Order44-53-190(F)
4-Methyl-alpha-ethylaminopentiophenone, its optical, positional, and geometric isomers, salts and salts of isomers (Other names: 4–MEAP; 2-(ethylamino)-1-(4-methylphenyl)pentan-1-one)4-MEAPC-I8/8/2019Board Order44-53-190(F)
4′-Methyl-alpha-pyrrolidinohexiophenone, its optical, positional, and geometric isomers, salts and salts of isomers  (Other names: MPHP; 4′-methyl-alpha-pyrrolidinohexanophenone; 1-(4-methylphenyl)-2-(pyrrolidin-1-yl)hexan-1-one)MPHPC-I8/8/2019Board Order44-53-190(F)
alpha-Pyrrolidinoheptaphenone, its optical, positional, and geometric isomers, salts and salts of isomers  (Other names: PV8; 1-phenyl-2-(pyrrolidin-1-yl)heptan-1-one)PV8C-I8/8/2019Board Order44-53-190(F)
4′-Chloro-alpha-pyrrolidinovalerophenone, its optical, positional, and geometric isomers, salts and salts of isomers  (Other names: 4-chloro-α-PVP; 4′-chloro-alpha-pyrrolidinopentiophenone; 1-(4-chlorophenyl)-2-(pyrrolidin-1-yl)pentan-1-one)4-Chloro-α-PVPC-I8/8/2019Board Order44-53-190(F)
Solriamfetol (2-amino-3-phenylpropyl car-bamate; benzenepropanol, beta-amino-, carbamate (ester))SolriamfetolC-IV7/11/2019Board Order44-53-250(b)
BrexanoloneBrexanoloneC-IV7/11/2019Board Order44-53-250(a)
ethyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate, its optical, positional, and geometric isomers, salts and salts of isomers5F-EDMB-PINACAC-I5/9/2019Board Order44-53-190(D)
methyl 2-(1-(5-fluoropentyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate, its optical, positional, and geometric isomers, salts and salts of isomers5F-MDMB-PICAC-I5/9/2019Board Order44-53-190(D)
N-(adamantan-1-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide, its optical, positional, and geometric isomers, salts and salts of isomersFUB-AKB48; FUB-APINACA; AKB48 N-(4-FLUOROBENZYL)C-I5/9/2019Board Order44-53-190(D)
1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide, its optical, positional, and geometric isomers, salts and salts of isomers5F-CUMYL-PINACA; SGT-25C-I5/9/2019Board Order44-53-190(D)
(1-(4-fluorobenzyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl) methanone, its optical, positional, and geometric isomers, salts and salts of isomersFUB-144C-I5/9/2019Board Order44-53-190(D)
N-Ethylpentylone, its optical, positional, and geometric isomers, salts and salts of isomersephylone,  N-1-(1,3-benzodioxol-5-yl)-2-(ethylamino)-1-pentanoneC-I9/27/2018Board Order44-53-190(F)(4)
Naphthalen-1-yl 1-(5-fluoropentyl)-1 H-indole-3-carboxylate, its optical, positional, and geometric isomers, salts and salts of isomersNM2201; CBL2201C-I7/12/2018Board Order
44-53-190(D)
N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1 H-indazole-3-carboxamide, its optical, positional, and geometric isomers, salts and salts of isomers5F-AB-PINACAC-I7/12/2018Board Order
44-53-190(D)
1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1 H-indazole-3-carboxamide, its optical, positional, and geometric isomers, salts and salts of isomers4-CN-CUMYL-BUTINACA; 4-cyano-CUMYL-BUTINACA; 4-CN-CUMYL BINACA; CUMYL-4CN-BINACA; SGT-78C-I7/12/2018Board Order
44-53-190(D)
methyl 2-(1-(cyclohexylmethyl)-1 H-indole-3-carboxamido)-3-methylbutanoate, its optical, positional, and geometric isomers, salts and salts of isomersMMB-CHMICA, AMB-CHMICAC-I7/12/2018Board Order
44-53-190(D)
1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1 H-pyrrolo[2,3-b]pyridine-3-carboxamide, its optical, positional, and geometric isomers, salts and salts of isomers5F-CUMYL-P7AICAC-I7/12/2018Board Order
44-53-190(D)
Fentanyl-related substances, their isomers, esters, ethers, salts and salts of isomers, esters and ethers. (a) Fentanyl-related substance means any substance that is structurally related to fentanyl by one or more of the following modifications: 1. Replacement of the phenyl portion of the phenethyl group by any monocycle, whether or not further substituted in or on the monocycle; 2. Substitution in or on the phenethyl group with alkyl, alkenyl, alkoxyl, hydroxyl, halo, haloalkyl, amino or nitro groups; 3. Substitution in or on the piperidine ring with alkyl, alkenyl, alkoxyl, ester, ether, hydroxyl, halo, haloalkyl, amino or nitro groups; 4. Replacement of the aniline ring with any aromatic monocycle whether or not further substituted in or on the aromatic monocycle; and/or 5. Replacement of the N-propionyl group by another acyl group. C-I2/8/2018Board Order44-53-190(B)
N-(1-phenethylpiperidin-4-yl)-N-phenylpentanamide, its isomers, esters, ethers, salts and salts of isomers, esters and        
ethers		Valeryl FentanylC-I2/8/2018Board Order44-53-190(B)
N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)butyramide, its isomers, esters, ethers, salts and salts of isomers, esters        
and ethers		Para-Fluorobutyryl FentanylC-I2/8/2018Board Order44-53-190(B)
N-(4-methoxyphenyl)-N-(1-phenethylpiperidin-4-yl)butyramide, its isomers, esters, ethers, salts and salts of isomers,        
esters and ethers		Para-Methoxybutyryl FentanylC-I2/8/2018Board Order44-53-190(B)
N-(4-chlorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide, its isomers, esters, ethers, salts and salts of isomers,        
esters and ethers		Para-Chloroisobutyryl FentanylC-I2/8/2018Board Order44-53-190(B)
N-(1-phenethylpiperidin-4-yl)-N-phenylisobutyramide, its isomers, esters, ethers, salts and salts of isomers, esters and        
ethers		Isobutyryl FentanylC-I2/8/2018Board Order44-53-190(B)
N-(1-phenethylpiperidin-4-yl)-N-phenylcyclopentanecarboxamide, its isomers, esters, ethers, salts and salts of isomers,        
esters and ethers		Cyclopentyl FentanylC-I2/8/2018Board Order44-53-190(B)
N-(2-fluorophenyl)-2-methoxy-N-(1-phenethylpiperidin-4-yl)acetamide, its isomers, esters, ethers, salts and salts of isomers,        
esters and ethers		OcfentanilC-I2/8/2018Board Order44-53-190(B)
N-(1-phenethylpiperidin-4-yl)-N-phenylcyclopropanecarboxamide(cyclopropyl fentanyl), its isomers, esters, ethers, salts and salts of isomers, esters and ethersCyclopropyl FentanylC-I1/30/2018Board Order44-53-190(B)
MT-45 (1-cyclohexyl-4-(1,2-diphenylethyl)piperazine)MT-45C-I1/4/2018Board Order44-53-190(B)
methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3-methylbutanoate, its isomers, esters, ethers, salts and salts of isomers, esters and ethersFUB-AMB, MMB-FUBINACA, AMB-FUBINACAC-I11/9/2017Board Order44-53-190(D)
N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide, its isomers, esters, ethers, salts and salts of isomers, esters and ethersOrtho-Fluorofentanyl, 2-FluorofentanylC-I11/9/2017Board Order44-53-190(B)
N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carboxamide, its isomers, esters, ethers, salts and salts of isomers, esters and ethersTetrahydrofuranyl FentanylC-I11/9/2017Board Order44-53-190(B)
2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide, its isomers, esters, ethers, salts and salts of isomers, esters and ethersMethoxyacetyl FentanylC-I11/9/2017Board Order44-53-190(B)
N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide, its isomers, esters, ethers, salts and salts of isomers, esters and ethersAcryl FentanylC-I8/10/2017Board Order44-53-190(B)
4-Fluoroisobutyryl FentanylN-(4-fluorophenyl)-N-(1- phenethylpiperidin-4-yl)isobutyramide (4-fluoroisobutyryl fentanyl or parafluoroisobutyryl fentanyl)C-I5/11/2017Board Order44-53-190(B)
Dronabinol [(-)-delta-9-trans tetrahydrocannabinol (delta-9-THC)] in an oral solutionSyndrosC-II4/5/2017Board Order44-53-210 (Other)
N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-2-carboxamideFuranyl FentanylC-I12/8/2016Board Order44-53-190(B)
3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamideU-47700, (9547), PINKC-I11/10/2016Board Order44-53-190(B)
(4-(methoxycarbonyl)-4-(N-phenmethoxyacetamido)-1-[2-(thienyl)ethyl]piperidine)ThiafentanilC-II9/8/2016Board Order44-53-210(c)
(4-(methoxycarbonyl)-4-(N-phenmethoxyacetamido)-1-[2-(thienyl)ethyl]piperidine)ThiafentanylC-II9/8/2016Board Order44-53-210(c)
((2S)-2-[4R)-2-oxo-4-propypyrrolidin-1-yl] butanamide)BrivaracetamBRV, UCB-34714, BriviactC-V6/9/2016Board Order44-53-270(c)
3,4-dichloro-N-[(1-dimethylamino)cyclohexylmethyl]benzamideAH-7921C-I5/12/2016Board Order44-53-190(B)
N-(1-phenethylpiperidin-4-yl)-N-phenylbutyramideButyryl FentanylC-I5/12/2016Board Order44-53-190(B)
N-[1-[2-hydroxy-2-(thiophen-2-yl)ethyl]piperidin-4-yl]-N-phenylpriopionamideBeta-HydroxythiofentanylC-I5/12/2016Board Order44-53-190(B)
Updated Definition of Substiuted Cathinones to include underlined portion: (4) Substituted Cathinones, Any compound (not being bupropion) structurally derived from 2-amino-1-phenyl-1-propanone by modification in any of the following ways: (a) by substitution in the phenyl ring to any extent with alkyl, alkenyl, alkoxy, alkylendioxy, haloalkyl, or halide subsituents, whether or not further substituted in the phenyl ring by one or more univalent substituents; (b) by substitution at the 3-position with an alkyl substituent; (c) by substitution at the nitrogen atom with alkyl or dialkyl groups, benzyl, or methoxybenzyl groups; or (d) by inclusion of the nitrogen atom in a cyclic structure.Including but not limited to: Methylone, Mephedrone, MDPV, Butylone, Methedrone, 4-MEC, Flephedrone, Pentylone, Pentedrone, Buphedrone, alpha-PVP, 4-MePPP, 4-FMC, 3-FMC, alpha-PBP, naphyroneC-I3/10/2016Board Order44-53-190(F)
5-[[[(2s)-2-3-[4-aminocarbonyl)-2,6-dimethylphenyl]-1-oxopropyl][(1S)-1-(4-phenyl-1H-imidazol-2-yl)ethyl]amino]methyl]2-methoxybenzoic acidEluxadolineC-IV12/10/2015Board Order44-53-250(e)
N-(1- phenethylpiperidin-4-yl)-N-phenylacetamideAcetyl FentanylC-I6/11/2015Board Order44-53-190(B)
Syntehtic Cannabinoids: Indazole-3-carboxamides. Any compound containing an Indazole-3-carboxamide structure with substitution at the nitrogen atom of the indazole ring by alkyl, haloalkyl, halobenzyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, (1-(N-methyl-2-piperidinyl)methyl, (tetrahydro-2H-pyran-4-yl)methyl or (morpholinyl) ethyl group, whether or not further substituted in the indole ring to any extent. Including, but not limited, to AKB-48, AB-FUBINACA, AB-PINACA, ADB-FUBINACA, ADB-PINACA.AKB-48, AB-FUBINACA, AB-PINACA, ADB-FUBINACA, ADB-PINACA, AB-CHMINACA, THJ-2201, 5-Fluoro-AMBC-I12/11/2014Board Order44-53-190(D)
13-beta-ethyl-17beta-hydroxygon-4-en-3-one C-III12/8/2022Board Order44-53-230
17-alpha-methyl-3alpha,17beta-dihydroxy-5alpha-androstane C-III12/8/2022Board Order44-53-230
17-alpha-methyl-3beta,17beta-dihydroxy-5alpha-androstane C-III12/8/2022Board Order44-53-230
17-alpha-methyl-3beta,17beta-dihydroxyandrost-4-ene C-III12/8/2022Board Order44-53-230
17-alpha-methyl-4-hydroxynandrolone C-III12/8/2022Board Order44-53-230
17-alpha-methyl-delta1-dihydrotestosterone C-III12/8/2022Board Order44-53-230
19-nor-4,9(10)-androstadienedione C-III12/8/2022Board Order44-53-230
19-nor-4-androstenediol C-III12/8/2022Board Order44-53-230
19-nor-4-androstenedione C-III12/8/2022Board Order44-53-230
19-nor-5-androstenediol C-III12/8/2022Board Order44-53-230
19-nor-5-androstenedione C-III12/8/2022Board Order44-53-230
1-androstenediol C-III12/8/2022Board Order44-53-230
1-androstenedione C-III12/8/2022Board Order44-53-230
3-alpha,17beta-dihydroxy-5alpha-androstane C-III12/8/2022Board Order44-53-230
3-beta,17beta-dihydroxy-5alpha-androstane C-III12/8/2022Board Order44-53-230
4-androstenediol C-III12/8/2022Board Order44-53-230
4-androstenedione C-III12/8/2022Board Order44-53-230
4-dihydrotestosterone C-III12/8/2022Board Order44-53-230
4-hydroxy-19-nortestosterone C-III12/8/2022Board Order44-53-230
4-hydroxytestosterone C-III12/8/2022Board Order44-53-230
5-androstenediol C-III12/8/2022Board Order44-53-230
5-androstenedione C-III12/8/2022Board Order44-53-230
androstanedione C-III12/8/2022Board Order44-53-230
bolasterone C-III12/8/2022Board Order44-53-230
boldenone C-III12/8/2022Board Order44-53-230
boldione C-III112/8/2022Board Order44-53-230
calusterone C-III12/8/2022Board Order44-53-230
delta1-dihydrotestosterone C-III12/8/2022Board Order44-53-230
desoxymethyltestosterone C-III12/8/2022Board Order44-53-230
drostanolone C-III12/8/2022Board Order44-53-230
formebolone C-III12/8/2022Board Order44-53-230
furazabol C-III12/8/2022Board Order44-53-230
mestanolone C-III12/8/2022Board Order44-53-230
methandriol C-III12/8/2022Board Order44-53-230
methyldienolone C-III12/8/2022Board Order44-53-230
methyltrienolone C-III12/8/2022Board Order44-53-230
mibolerone C-III12/8/2022Board Order44-53-230
norbolethone C-III12/8/2022Board Order44-53-230
norclostebol C-III12/8/2022Board Order44-53-230
normethandrolone C-III12/8/2022Board Order44-53-230
prostanozol C-III12/8/2022Board Order44-53-230
stenbolone C-III12/8/2022Board Order44-53-230
testolactone C-III12/8/2022Board Order44-53-230
tetrahydrogestrinone C-III12/8/2022Board Order44-53-230
trenbolone C-III12/11/2014Board Order44-53-230
2-(2,5-Dimethoxy-4-ethylphenyl) ethanamine2C-EC-I12/11/2014Board Order44-53-190(D)
2-(4-Iodo-2,5-dimethoxyphenyl) ethanamine2C-IC-I12/11/2014Board Order44-53-190(D)
1-(2-phenethyl)-4-phenyl-4-acetoxypiperidinePEPAPC-I12/11/2014Board Order44-53-190(B)
1-[1-(2-Thienyl)cyclohexyl]pyrrolidineTCPyC-I12/11/2014Board Order44-53-190(D)
1-Methyl-4-phenyl-4-propionoxypiperidineMPPPC-I12/11/2014Board Order44-53-190(B)
2-(2,5-Dimethoxy-4-(n)-prophylphenyl) ethanamine2C-PC-I12/11/2014Board Order44-53-190(D)
2-(2,5-Dimethoxy-4-methylphenyl) ethanamine2C-DC-I12/11/2014Board Order44-53-190(D)
2-(2,5-Dimethoxy-4-nitro-phenyl) ethanamine2C-NC-I12/11/2014Board Order44-53-190(D)
2-(2,5-Dimethoxyphenyl) ethanamine2C-HC-I12/11/2014Board Order44-53-190(D)
2-(4-Chloro-2,5-dimethoxyphenyl) ethanamine2C-CC-I12/11/2014Board Order44-53-190(D)
2-(4-ethylthio-2,5-dimethoxyphenyl) ethanamine2C-T-2C-I12/11/2014Board Order44-53-190(D)
2-(4-ethylthio-2,5-dimethoxyphenyl) ethanamine2C-T-4C-I12/11/2014Board Order44-53-190(D)
2,5-Dimethoxy-4-(n)propylthiophenethylamine2C-T-7C-I12/11/2014Board Order44-53-190(D)
2,5-Dimethoxy-4-ethylamphetamineDOE, DOET, HecateC-I12/11/2014Board Order44-53-190(D)
3,4-Methylenedioxy-N-ethylamphetamineMDEAC-I12/11/2014Board Order44-53-190(D)
3-Methoxy-4,5-methylenedioxyamphetamineMMDAC-I12/11/2014Board Order44-53-190(D)
3-Methylfentanyl C-I12/11/2014Board Order44-53-190(B)
3-Methylthiofentanyl C-I12/11/2014Board Order44-53-190(B)
4-Methylaminorex (cis isomer) C-I12/11/2014Board Order44-53-190(F)
5 Methoxy-N,N,Dimethyltryptamine5-MeO-DMTC-I12/11/2014Board Order44-53-190(D)
5-Iodo-2-aminoindane5-IAIC-I12/11/2014Board Order44-53-190(D)
5-Methoxy-N,N-diisopropyltryptamine5-MeO-DIPTC-I12/11/2014Board Order44-53-190(D)
Acetyl-alpha-methylfentanyl C-I12/11/2014Board Order44-53-190(B)
Alpha-ethyltryptaminealpha-ETC-I12/11/2014Board Order44-53-190(D)
Alpha-methylthiofentanyl C-I12/11/2014Board Order44-53-190(B)
Alpha-methyltryptamineAMTC-I12/11/2014Board Order44-53-190(D)
Aminorex C-I12/11/2014Board Order44-53-190(F)
Beta-hydroxy-3-methylfentanyl C-I12/11/2014Board Order44-53-190(B)
Beta-hydroxyfentanyl C-I12/11/2014Board Order44-53-190(B)
CyclohexamineEthylamine analog of phencyclidine, PCEC-I12/11/2014Board Order44-53-190(D)
N,N-DimethylamphetamineMetrotoninC-I12/11/2014Board Order44-53-190(F)
N-BenzylpiperazineBZPC-I12/11/2014Board Order44-53-190(F)
Para-Fluorofentanyl C-I12/11/2014Board Order44-53-190(B)
RolicyclidinePyrrolidine analog of phencyclidine, PHP, PCPyC-I12/11/2014Board Order44-53-190(D)
Synthetic Cannabinoid: Indole -3-carboxamides. Any compound containing an Indole-3-carboxamide structure with substitution at the nitrogen atom of the indole ring by alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, (1-(N-methyl-2-piperidinyl)methyl, (tetrahydro-2H-pyran-4-yl)methyl or (morpholinyl) ethyl group, whether or not further substituted in the indole ring to any extent. Including, but not limited, to STS-135.STS-135C-I12/11/2014Board Order44-53-190(D)
Synthetic Cannabinoid: Indazole-3-carboxamides. Any compound containing an Indazole-3-carboxamide structure with substitution at the nitrogen atom of the indazole ring by alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, (1-(N-methyl-2-piperidinyl)methyl, (tetrahydro-2H-pyran-4-yl)methyl or (morpholinyl) ethyl group, whether or not further substituted in the indole ring to any extent. Including, but not limited, to AKB-48, AB-FUBINACA, AB-PINACA, ADB-FUBINACA, ADB-PINACA.AKB-48, AB-FUBINACA, AB-PINACA, ADB-FUBINACA, ADB-PINACA, AB-CHMINACA, THJ-2201, 5-Fluoro-AMBC-I12/11/2014Board Order44-53-190(D)
Synthetic Cannabinoid: N-cyclopropyl-11-(2-hexyl-5-hydroxyphenoxy)-undecanamideCB-52C-I12/11/2014Board Order44-53-190(D)
Synthetic Cannabinoid: N-cyclopropyl-11-(3-hydroxy-5-pentylphenoxy)-undecanamideCB-25C-I12/11/2014Board Order44-53-190(D)
Synthetic Cannabinoid: N-cyclopropyl-8-[3-(1,1-dimethylheptyl)-5-hydroxyphenoxy]-octanamideCB-86C-I12/11/2014Board Order44-53-190(D)
Synthetic Cannabinoid: (6aR,9R,10aR)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,8,9,10,10a-hexahydrobenzo [c]chromene-1,9-diolHU-243, CanbisolC-I12/11/2014Board Order44-53-190(D)
Synthetic Cannabinoid: [(6S,6aR, 9R,10aR)-9-hydroxy-6-methyl-3-[(2R)-5-phenylpentan-2-yl]oxy-5,6,6a,7,8,9,10,10a-octahydrophenanthridin-1-yl] acetateLevantradol, CP 50,556-1C-I12/11/2014Board Order44-53-190(D)
Synthetic Cannabinoid: 1-napthalenyl[4-(pentylox)-1-napthalenyl]-methanoneCB-13, CRA-13C-I12/11/2014Board Order44-53-190(D)
Synthetic Cannabinoid: 3-hydroxy-2-[(1R,6R)-3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-2,5-cyclohexadiene-1,4-dioneHU-331C-I12/11/2014Board Order44-53-190(D)
Synthetic Cannabinoid: 4-[4-(1,1-dimethylheptyl)-2,6-dimethoxyphenyl]-6,6-dimethyl-bicyclo[3.1.1] hept-2-ene-2-methanolHU-308C-I12/11/2014Board Order44-53-190(D)
Synthetic Cannabinoids: Quinolinyl-Indole Carboxylates. Any compound containing a quinolinyl-indole-3-carboxylate structure with substitution of the nitrogen atom of the indole ring by alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, (1-(N-methyl-2-piperidinyl)methyl, (tetrahydro-2H-pyran-4-yl)methyl or (morpholinyl) ethyl group, whether or not further substituted in the indole ring or quinolinyl structure to any extent. Including but not limited to PB-22, 5-F-PB-22.PB-22; 5-F-PB-22; BB-22C-I12/11/2014Board Order44-53-190(D)
Synthetic Cannaninoid: Indole - 3-ylcycloalkyl ketones. Any compound containing an Indole-3-ylcycloalkyl ketone structure with substitution at the nitrogen atom of the indole ring by alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, (1-(N-methyl-2-piperidinyl)methyl, (tetrahydro-2H-pyran-4-yl)methyl or (morpholinyl)ethyl group, whether or not further substituted in the indole ring to any extent or whether or not substituted at the cycloalkyl ring to any extent. Including, but not limited to, XLR-11, UR-144, A-834735, A-796260, AB-001, AB-005XLR-11, UR-144, A-834735, A-796260, AB-001, AB-005, 5-bromo-UR-144, 5-chloro-UR-144, 5-fluoro-144, AB-034C-I12/11/2014Board Order44-53-190(D)
Synthetic Cannabinoid: 3-hydroxy-2-[(1R,6R)-3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-2,5-cyclohexadiene-1,4-dioneHU-331C-I12/11/2014Board Order44-53-190(D)
Tenocyclidine1-[1-(2-Thienyl)cyclohexyl]piperidine, TCPC-I12/11/2014Board Order44-53-190(D)
Thiofentanyl C-I12/11/2014Board Order44-53-190(B)
4-Anilino-N-phenethyl-4-piperidineANPPC-II12/11/2014Board Order44-53-210(c)
Alfentanil C-II12/11/2014Board Order44-53-210(c)
Dihydroetorphine C-II12/11/2014Board Order44-53-210(c)
Diprenorphine C-II12/11/2014Board Order44-53-210(c)
Levo-alphacetylmethadolLAAMC-II12/11/2014Board Order44-53-210(c)
Lisdexamfetamine C-II12/11/2014Board Order44-53-210(d)
Nabilone C-II12/11/2014Board Order44-53-210(h)
Oripavine C-II12/11/2014Board Order44-53-210(c)
Oxycodone C-II12/11/2014Board Order44-53-210(c)
Remifentanil C-II12/11/2014Board Order44-53-210(c)
Tapentadol C-II12/11/2014Board Order44-53-210(c)
Thebaine C-II12/11/2014Board Order44-53-210(c)
Buprenorphine C-III12/11/2014Board Order44-53-230(e)
Dronabinol in sesame oil and encapsulated in a soft gelatin capsulemarinol - synthetic delta 9 tetrahydrocannabinol (THC)C-III12/11/2014Board Order44-53-230(e)
Embutramide C-III12/11/2014Board Order44-53-230(c)
Ketamine C-III12/11/2014Board Order44-53-230(c)
Sulfonmethane C-III12/11/2014Board Order44-53-230(c)
Tiletamine & Zolazepam Combination Product C-III12/11/2014Board Order44-53-230(c)
Cathine C-IV12/11/2014Board Order44-53-250(b)
Dichloralphenazone C-IV12/11/2014Board Order44-53-250(a)
Fencamfamin C-IV12/11/2014Board Order44-53-250(b)
Fenproporex C-IV12/11/2014Board Order44-53-250(b)
Fospropofol C-IV12/11/2014Board Order44-53-250(a)
Mefenorex C-IV12/11/2014Board Order44-53-250(b)
Midazolam C-IV12/11/2014Board Order44-53-250(a)
Modafinil C-IV12/11/2014Board Order44-53-250(b)
Phenazepam C-IV12/11/2014Board Order44-53-250(a)
Pyrazolam C-IV12/11/2014Board Order44-53-250(a)
Quazepam C-IV12/11/2014Board Order44-53-250(a)
Sibutramine C-IV12/11/2014Board Order44-53-250(b)
Zaleplon C-IV12/11/2014Board Order44-53-250(a)
Zolpidem C-IV12/11/2014Board Order44-53-250(a)
Zopiclone C-IV12/11/2014Board Order44-53-250(a)
Lacosamide C-V12/11/2014Board Order44-53-270(c)
Pregabalin C-V12/11/2014Board Order44-53-270(c)
Pyrovalerone C-V12/11/2014Board Order44-53-270(d)
[(7R)-4-(5-chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl}{5=methyl-2-(2H-123-triazol-2-yl)phenyl]methanoneSuvorexantC-IV9/25/2014Board Order44-53-250(a)
Dihydrocodeine - Not more than 1.8 grams of dihydrocodeine per 100 milliliters or not more than 90 milligrams per dosage unit, with one or more active, non-narcotic ingredients in recognized therapeutic amounts. C-II9/11/2014Board Order44-53-230(e)
Dihydrocodeine - Not more than 300 milligrams of dihydrocodeinone per 100 milliliters or not more than 15 milligrams per dosage unit, with a four-fold or greater quantity of an isoquinoline alkaloid of opium. C-II9/11/2014Board Order44-53-230(e)
Dihydrocodeine - Not more than 300 milligrams of dihydrocodeinone per 100 milliliters or not more than 15 milligrams per dosage unit, with one or more active, non-narcotic ingredients in recognized therapeutic amounts. C-II9/11/2014Board Order44-53-230(e)
Hydrocodone Combination ProductsLortabC-II9/11/2014Board Order44-53-210(c)
2-[(dimethylamino)methyl]-1-(3-Methoxyphenyl)cyclohexanolTramadolC-IV7/10/2014Board Order44-53-250(e)
AlfaxaloneAlfaxaloneC-IV3/13/2014Board Order44-53-250(a)
Synthetic Cannabinoid: N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamideADB-PINACAC-I2/27/2014Board Order44-53-190(D)
Synthetic Cannabinoid: N-(1-amino-3-methyl-1-oxobutan-2-yl-1-(4-fluorobenzyl)-1H-indazole-3-carboxamideAB-FUBINACAC-I2/27/2014Board Order44-53-190(D)
Synthetic Cannabinoid: Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3 carboxylate5-fluoro-PB-22; 5F-PB-22C-I2/27/2014Board Order44-53-190(D)
Synthetic Cannabinoid: Quinolin-8-yl 1-pentyl-1H-indole-3-carboxylatePB-22; QUPICC-I2/27/2014Board Order44-53-190(D)
2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine25B-NBOMe; 2C-B-NBOMe; 25B; Cimbi-36C-I12/12/2013Board Order44-53-190(D)
2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine25C-NBOMe; 2C-C-NBOMe; 25C; Cimbi-82C-I12/12/2013Board Order44-53-190(D)
2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine25I-NBOMe; 2C-I-NBOMe; 25I; Cimbi-5C-I12/12/2013Board Order44-53-190(D)
LorcaserinLorcaserinC-IV6/4/2013Board Order44-53-250(c)
Synthetic Cannabinoid: 1-(5-fluoro-pentyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl) methanone5-fluoro-UR-144; XLR-11; XLRl 1C-I5/9/2013Board Order44-53-190(D)
Synthetic Cannabinoid: 1-pentyl-1H-indol-3-yl(2,2,3,3-tetramethylcyclopropyl) methanoneUR-144C-I5/9/2013Board Order44-53-190(D)
Synthetic Cannabinoid: N-(1-adamantyl)-1-pentyl-1H-indazole-3-carboxamideAPINACA, AKB48C-I5/9/2013Board Order44-53-190(D)
CarisoprodolSomaC-IV2/9/2012Board Order44-53-250(a)
Carisoprodol+AspirinSOMA CompoundC-IV2/9/2012Board Order44-53-250(a)
3,4-methylenedioxy-N-methylcathinoneMethyloneC-I10/24/2011Board Order44-53-190(F)
3,4-methylenedioxypyrovaleroneMDPVC-I10/24/2011Board Order44-53-190(F)
4-methyl-N-methylcathinoneMephedroneC-I10/24/2011Board Order44-53-190(F)
Synthetic Cannabinoid: 1-Butyl-3-(1-napthoyl)indoleJWH-073C-I10/24/2011Board Order44-53-190(D)
Synthetic Cannabinoid: 1-Pentyl-3-(1-napthoyl)indoleJWH-018; AM678C-I10/24/2011Board Order44-53-190(D)
Synthetic Cannabinoid: 5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenolCP-47,497C-I10/24/2011Board Order44-53-190(D)
Synthetic Cannabinoid: 5-(1,1-Dimethyloctyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenolcannabicyclohexanol; CP-47,497 C8 homologueC-I10/24/2011Board Order44-53-190(D)
Synthetic Cannabinoid: 1-[2-(4-Morpholinyl)ethyl]-3-(1-napthoyl)indoleJWH-200C-I10/24/2011Board Order44-53-190(D)
Ethylestrenol C-III12/8/2022Board Order44-53-230
Fluoxymesterone C-III12/8/2022Board Order44-53-230
Mesterolone C-III12/8/2022Board Order44-53-230
Methandienone C-III12/8/2022Board Order44-53-230
Methandrostenolone C-III12/8/2022Board Order44-53-230
Methenolone C-III12/8/2022Board Order44-53-230
Methyltestosterone C-III12/8/2022Board Order44-53-230
Nandrolone C-III12/8/2022Board Order44-53-230
Norethandrolone C-III12/8/2022Board Order44-53-230
Oxandrolone C-III12/8/2022Board Order44-53-230
Oxymesterone C-III12/8/2022Board Order44-53-230
Oxymetholone C-III12/8/2022Board Order44-53-230
Stanozolol C-III12/8/2022Board Order44-53-230
Testosterone C-III12/8/2022Board Order44-53-230
2,5-dimethoxyamphetamine C-I  44-53-190(D)
3,4,5-trimethoxy amphetamine C-I  44-53-190(D)
3,4-methylenedioxy amphetamine C-I  44-53-190(D)
3,4-methylenedioxymethamphetamine (MDMA) C-I  44-53-190(D)
4-bromo-2,5-dimethoxyamphetamine C-I  44-53-190(D)
4-Methoxyamphetamine C-I  44-53-190(D)
4-methyl-2,5-dimethoxyamphetamine (STP) C-I  44-53-190(D)
5-methoxy-3,4-methylenedioxy amphetamine C-I  44-53-190(D)
Acetorphine C-I  44-53-190(C)
Acetyldihydrocodeine C-I  44-53-190(C)
Acetylmethadol C-I  44-53-190(B)
Alfentanyl C-I  44-53-190(B)
Allylprodine C-I  44-53-190(B)
Alphameprodine C-I  44-53-190(B)
Alphamethadol C-I  44-53-190(B)
Alphamethylfentanyl (N-[1-(alpha-methyl-beta-phenyl) ethyl-4-piperidyl] propionanilide; 1-(1-methyl-2-phenylethyl-4-(N-pro-panilido) piperidine) C-I  44-53-190(B)
Any compound (not being bupropion) structurally derived from 2-amino-1-phenyl-1-propanone by modification in any of the following ways: (a) by substitution in the phenyl ring to any extent with alkyl, alkoxy, alkylenedioxy, haloalkyl or halide substituents, whether or not further substituted in the phenyl ring by one or more univalent substituents; (b) by substitution at the 3-position with an alkyl substituent; (c) by substitution at the nitrogen atom with alkyl or dialkyl groups, benzyl or methoxybenzyl groups; or (d) by inclusion of the nitrogen atom in a cyclic structureIncluding, but not limited to: Methylone, Mephedrone, 3,4-Methylenedioxypyrovalerone (MDPV), Butylone, Methedrone, 4-Methylethcathinone, Flephedrone, Pentylone, Pentedrone, BuphedroneC-I  44-53-190(F)
Benzethidine C-I  44-53-190(B)
Benzylmorphine C-I  44-53-190(C)
Betacetylmethadol C-I  44-53-190(B)
Betameprodine C-I  44-53-190(B)
Betamethadol C-I  44-53-190(B)
Betaprodine C-I  44-53-190(B)
Bufotenine C-I  44-53-190(D)
Cathinone C-I  44-53-190(F)
Clonitazene C-I  44-53-190(B)
Codeine methylbromide C-I  44-53-190(C)
Codeine-N-Oxide C-I  44-53-190(C)
Cyprenorphine C-I  44-53-190(C)
Desomorphine C-I  44-53-190(C)
Dextromoramide C-I  44-53-190(B)
Diampromide C-I  44-53-190(B)
Diethylthiambutene C-I  44-53-190(B)
Diethyltryptamine (DET) C-I  44-53-190(D)
Difenoxin C-I  44-53-190(B)
Dihydromorphine C-I  44-53-190(C)
Dimenoxadol C-I  44-53-190(B)
Dimepheptanol C-I  44-53-190(B)
Dimethylthiambutene C-I  44-53-190(B)
Dimethyltryptamine (DMT) C-I  44-53-190(D)
Dioxaphetyl butyrate C-I  44-53-190(B)
Dipipanone C-I  44-53-190(B)
Drotebanol C-I  44-53-190(C)
Ethylmethylthiambutene C-I  44-53-190(B)
Etonitazene C-I  44-53-190(B)
Etorphine C-I  44-53-190(C)
Etoxeridine C-I  44-53-190(B)
Fenethylline C-I  44-53-190(F)
Furethidine C-I  44-53-190(B)
Gamma Hydroxybutyric Acid C-I  44-53-190(E)
Heroin C-I  44-53-190(C)
Hydromorphinol C-I  44-53-190(C)
Hydroxypethidine C-I  44-53-190(B)
Ibogaine C-I  44-53-190(D)
Ketobemidone C-I  44-53-190(B)
Levomoramide C-I  44-53-190(B)
Levophenacylmorphan C-I  44-53-190(B)
Lysergic acid diethylamide (LSD) C-I  44-53-190(D)
Marijuana C-I  44-53-190(D)
Mecloqualone C-I  44-53-190(E)
Mescaline C-I  44-53-190(D)
Methaqualone C-I  44-53-190(E)
Methyldesorphine C-I  44-53-190(C)
Methylhydromorphine C-I  44-53-190(C)
Morpheridine C-I  44-53-190(B)
Morphine methylbromide C-I  44-53-190(C)
Morphine methylsulfonate C-I  44-53-190(C)
Morphine-N-Oxide C-I  44-53-190(C)
Myrophine C-I  44-53-190(C)
N-ethyl-3-piperidyl benzilate C-I  44-53-190(D)
N-ethylamphetamine C-I  44-53-190(F)
Nicocodeine C-I  44-53-190(C)
Nicomorphine C-I  44-53-190(C)
N-methyl-3-piperidyl benzilate C-I  44-53-190(D)
Noracymethadol C-I  44-53-190(B)
Norlevorphanol C-I  44-53-190(B)
Normethadone C-I  44-53-190(B)
Normorphine C-I  44-53-190(C)
Norpipanone C-I  44-53-190(B)
Parahexyl C-I  44-53-190(D)
Peyote C-I  44-53-190(D)
Phenadoxone C-I  44-53-190(B)
Phenampromide C-I  44-53-190(B)
Phenomorphan C-I  44-53-190(B)
Phenoperidine C-I  44-53-190(B)
Pholcodine C-I  44-53-190(C)
Piritramide C-I  44-53-190(B)
Proheptazine C-I  44-53-190(B)
Properidine C-I  44-53-190(B)
Propiram C-I  44-53-190(B)
Psilocybin C-I  44-53-190(D)
Psilocyn C-I  44-53-190(D)
Racemoramide C-I  44-53-190(B)
Substituted Cathinones C-I  44-53-190(F)
Synthetic Cannabinoid 24 (d.) Naphthylmethylindenes. Any compound containing a naphthylideneindene structure with substitution at the 3-position of the indene ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indene ring to any extent and whether or not substituted in the naphthyl ring to any extent C-I  44-53-190(D)
Synthetic Cannabinoid 24 (e.) Phenylacetylindoles. Any compound containing a 3-phenylacetylindole structure with substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indole ring to any extent and whether or not substituted in the phenyl ring to any extent.Including, but not limited to, SR-18, RCS-8, JWH-203, JWH-250, JWH-251, JWH-302C-I  44-53-190(D)
Synthetic Cannabinoid 24 (f.) Cyclohexylphenols. Any compound containing a 2-(3-hydroxycyclohexyl)phenol structure with substitution at the 5-position of the phenolic ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group, whether or not substituted in the cyclohexyl ring to any extent.Including, but not limited to, CP 47,497 (and homologues), cannabicyclohexanol, CP-55, 940.C-I  44-53-190(D)
Synthetic Cannabinoid 24 (h.) 2,3-Dihydro-5-methyl-3-(4-morpholinylmethyl)pyrrolo [1,2,3-de]-1, 4-benzoxazin-6-yl]-1-napthalenylmethanone (WIN 55,212-2)WIN 55,212-2C-I  44-53-190(D)
Synthetic Cannabinoid 24 (i.) 9-(hydroxymethyl)-6,6-dimethy l-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol 7370 (HU-210, HU-211)HU-210, HU-211C-I  44-53-190(D)
Synthetic Cannabinoid 24 (j.) Adamantoylindoles. Any compound containing a 3-(1-adamantoyl)indole structure with substitution at the nitrogen atom of the indole ring by a alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indole ring to any extent and whether or not substituted in the adamantyl ring system to any extentIncluding but not limited to: AB-001, AB-002, AM1248C-I  44-53-190(D)
Synthetic Cannabinoid 24(g.) Benzoylindoles. Any compound containing a 3-(benzoyl)indole structure with substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indole ring to any extent and whether or not substituted in the phenyl ring to any extent.Including, but not limited to, AM-694, Pravadoline (WIN 48,098), RCS-4, AM-630, AM-1241, AM-2233C-I  44-53-190(D)
Synthetic Cannabinoid 24. (a.) Naphthoylindoles. Any compound containing a 3-(1-naphthoyl)indole structure with substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indole ring to any extent and whether or not substituted in the naphthyl ring to any extent.Including, but not limited to, JWH-015, JWH-018, JWH-019, JWH-073, JWH-081, JWH-122, JWH-200, JWH-210, JWH-398, AM-2201, WIN 55-212, AM-2201 (C1 analog), AM-1220C-I  44-53-190(D)
Synthetic cannabinoid 24. (b.) Naphthylmethylindoles. Any compound containing a 1H-indol-3-yl-(1-naphthyl)methane structure with substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indole ring to any extent and whether or not substituted in the naphthyl ring to any extentIncluding but not limited to: JWH-175, JWH-184C-I  44-53-190(D)
Synthetic Cannabinoid 24. (c.) Naphthoylpyrroles. Any compound containing a 3-(1-naphthoyl)pyrrole structure with substitution at the nitrogen atom of the pyrrole ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the pyrrole ring to any extent and whether or not substituted in the naphthyl ring to any extent.Including, but not limited to, JWH-307, JWH-370, JWH-176C-I  44-53-190(D)
Synthetic cannabinoids.--24. Any material, compound, mixture, or preparation that is not listed as a controlled substance in Schedule I through V, is not an FDA-approved drug, and contains any quantity of the following substances, their salts, isomers (whether optical, positional, or geometric), homologues, and salts of isomers and homologues, unless specifically excepted, whenever the existence of these salts, isomers, homologues, and salts of isomers and homologues is possible within the specific chemical designation. C-I  44-53-190(D)
Tetrahydrocannabinol (THC) C-I  44-53-190(D)
Thebacon C-I  44-53-190(C)
Thiophene analog of phencyclidine C-I  44-53-190(D)
Tilidine C-I  44-53-190(B)
Trimeperidine C-I  44-53-190(B)
Alphaprodine C-II  44-53-210(c)
Amobarbital C-II  44-53-210(f)
Amphetamine, its salts, optical isomers, and salts of its optical isomers C-II  44-53-210(d)
Anileridine C-II  44-53-210(c)
Any salt, compound, isomer, derivative, or preparation thereof which is chemically equivalent or identical with any of the substances referred to in paragraph (1), but not including the isoquinoline alkaloids of opium C-II  44-53-210(b)
Bezitramide C-II  44-53-210(c)
Coca leaves and any salt, compound, derivative, or preparation of coca leaves, and any salt, compound, derivative, or preparation thereof which is chemically equivalent or identical with any of these substances, but not including decocainized coca leaves or extractions which do not contain cocaine or ecgonine C-II  44-53-210(b)
Dihydrocodeine C-II  44-53-210(c)
Diphenoxylate C-II  44-53-210(c)
Fentanyl C-II  44-53-210(c)
Isomethadone C-II  44-53-210(c)
Levomethorphan C-II  44-53-210(c)
Levorphanol C-II  44-53-210(c)
Metazocine C-II  44-53-210(c)
Methadone C-II  44-53-210(c)
Methadone - Intermediate, 4-cyano-2-dimethylamino-4, 4-diphenyl butane C-II  44-53-210(c)
Methamphetamine, its salts, and salts of isomers C-II  44-53-210(d)
Methylphenidate C-II  44-53-210(d)
Moramide - Intermediate, 2-methyl-3-morpholino-1, 1-diphenylpropane-carboxylic acid C-II  44-53-210(c)
Opium and opiate, and any salt, compound, derivative, or preparation of opium or opiate, excluding Apomorphine, Nalbuphine, Naloxone, and Naltrexone, and their respective salts C-II  44-53-210(b)
Opium poppy and poppy straw C-II  44-53-210(b)
Pentazocine (to be administered by injection only) C-II  44-53-210(c)
Pentobarbital C-II  44-53-210(f)
Pethidine - Intermediate-A, 4-cyano-1-methyl-4-phenyl-piperidine C-II  44-53-210(c)
Pethidine - Intermediate-B, ethyl-4-phenylpiperidine-4-carboxylate C-II  44-53-210(c)
Pethidine (meperidine) C-II  44-53-210(c)
Phenazocine C-II  44-53-210(c)
Phencyclidine immediate precursors: (a) 1-phenylcyclohexylamine; (b) 1-piperidinocyclohexanecarbonitrile (PCC); (g) Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substance: (1) Immediate precursor to amphetamine and methamphetamine: (i) Phenylacetone, also known as phenyl-2-propanone; P2P; benzyl methyl ketone; methyl benzyl ketone. C-II  44-53-210(f)
Phencyclidine C-II  44-53-210(f)
Phenmetrazine and its salts C-II  44-53-210(d)
Phenylacetone (Immediate precurser to amphetamine or methamphetamine)phenyl-2-propanone, P2P, benzyl methyl ketone, methyl benzyl ketoneC-II  44-53-210(g)
Piminodine C-II  44-53-210(c)
Racemethorphan C-II  44-53-210(c)
Racemorphan C-II  44-53-210(c)
Secobarbital C-II  44-53-210(f)
Sufentanil C-II  44-53-210(c)
any compound, mixture, or preparation containing amobarbital, secobarbital, pentobarbital or any salt thereof and one or more other active ingredients which are not listed in any schedule C-III  44-53-230(c)
any substance which contains any quantity of a derivative or barbituric acid or any salt thereof; C-III  44-53-230(c)
any suppository dosage form containing amobarbital, secobarbital, pentobarbital, or any salt of any of these drugs and approved by the United States Food and Drug Administration for marketing only as a suppository; C-III  44-53-230(c)
Benzphetamine C-III  44-53-230(b)
Chlorhexadol C-III  44-53-230(c)
Chlorphentermine C-III  44-53-230(b)
Clortermine C-III  44-53-230(b)
Gamma Hydroxybutyric Acid, and its salts, isomers, and salts of isomers contained in a drug product for which an application has been approved under Section 505 of the Federal Food, Drug and Cosmetic Act C-III  44-53-230(c)
Glutehimide C-III  44-53-230(c)
Lysergic Acid C-III  44-53-230(c)
Lysergic Acid Amide C-III  44-53-230(c)
Methyprylon C-III  44-53-230(c)
Nalorphene C-III  44-53-230(d)
Not more than 1.8 grams of codeine per 100 milliliters or not more than 90 milligrams per dosage unit, with an equal or greater quantity of an isoquinoline alkaloid of opium. C-III  44-53-230(e)
Not more than 1.8 grams of codeine per 100 milliliters or not more than 90 milligrams per dosage unit, with one or more active, non-narcotic ingredients in recognized therapeutic amounts C-III  44-53-230(e)
Not more than 300 milligrams of ethylmorphine per 100 milliliters or not more than 15 milligrams per dosage unit, with one or more active, non-narcotic ingredients in recognized therapeutic amounts. C-III  44-53-230(e)
Not more than 50 milligrams of morphine per 100 milliliters or per 100 grams with one or more active, non-narcotic ingredients in recognized therapeutic amounts. C-III  44-53-230(e)
Not more than 500 milligrams of opium per 100 milliliters or per 100 grams, or not more than 25 milligrams per dosage unit, with one or more active, non-narcotic ingredients in recognized therapeutic amounts. C-III  44-53-230(e)
Phendimetrazine C-III  44-53-230(b)
Sulfondiethylmethane C-III  44-53-230(c)
Sulfonethylmethane C-III  44-53-230(c)
Sulfonmethane C-III  44-53-230(c)
Alprazolam C-IV  44-53-250(a)
Barbital C-IV  44-53-250(a)
Bromazepam C-IV  44-53-250(a)
Butorphanol C-IV  44-53-250(g)
Camazepam C-IV  44-53-250(a)
Chloral Betaine C-IV  44-53-250(a)
Chloral Hydrate C-IV  44-53-250(a)
Chlordiazepoxide C-IV  44-53-250(a)
Clobazam C-IV  44-53-250(a)
Clonazepam C-IV  44-53-250(a)
Clorazepate C-IV  44-53-250(a)
Clotiazepam C-IV  44-53-250(a)
Cloxazolam C-IV  44-53-250(a)
Delorazepam C-IV  44-53-250(a)
Diazepam C-IV  44-53-250(a)
Diethylpropion C-IV  44-53-250(b)
Dosage forms of Dextropropoxyphene [Alpha-(+)-4-dimethylamino-1, 2-diphenyl-3-methyl-2-propionoxybutane] C-IV  44-53-250(e)
Estazolam C-IV  44-53-250(a)
Ethchlorvynol C-IV  44-53-250(a)
Ethinamate C-IV  44-53-250(a)
Fludiazepam C-IV  44-53-250(a)
Flunitrazepam C-IV  44-53-250(a)
Flurazepam C-IV  44-53-250(a)
Halazepam C-IV  44-53-250(a)
Haloxazolam C-IV  44-53-250(a)
Ketazolam C-IV  44-53-250(a)
Loprazolam C-IV  44-53-250(a)
Lorazepam C-IV  44-53-250(a)
Lormetazepam C-IV  44-53-250(a)
Mazindol C-IV  44-53-250(b)
Mebutamate C-IV  44-53-250(a)
Medazepam C-IV  44-53-250(a)
Meprobamate C-IV  44-53-250(a)
Methohexital C-IV  44-53-250(a)
Methylphenobarbital C-IV  44-53-250(a)
Nimetazepam C-IV  44-53-250(a)
Nitrazepam C-IV  44-53-250(a)
Nordiazepam C-IV  44-53-250(a)
Not more than one milligram of difenoxin and not less than twenty-five micrograms of atropine sulfate per dosage unit. C-IV  44-53-250(e)
Oxazepam C-IV  44-53-250(a)
Oxazolam C-IV  44-53-250(a)
Paraldehyde C-IV  44-53-250(a)
Pemoline, including organometallic complexes and chelates thereof C-IV  44-53-250(b)
Pentazocine hydrochloride and acetaminophen, pentazocine hydrochloride and aspirin, and pentazocine and naloxone hydrochloride (all for oral administration only). C-IV  44-53-250(f)
Petrichloral C-IV  44-53-250(a)
Phenobarbital C-IV  44-53-250(a)
Phentermine C-IV  44-53-250(b)
Pinazepam C-IV  44-53-250(a)
Pipradol C-IV  44-53-250(b)
Prazepam C-IV  44-53-250(a)
SPA [(-)-1-Dimethylamino-1, 2-diphenylethane] C-IV  44-53-250(b)
Temazepam C-IV  44-53-250(a)
Tetrazepam C-IV  44-53-250(a)
Triazolam C-IV  44-53-250(a)
Not more than 200 milligrams of codeine per 100 milliliter or per 100 grams C-V  44-53-250(b)
Not more than 100 milligrams of dihydrocodeine per 100 milliliters or per 100 grams; C-V  44-53-250(b)
Not more than 100 milligrams of ethylmorphine per 100 milliliters or per 100 grams; C-V  44-53-250(b)
Not more than 100 milligrams of opium per 100 milliliters or per 100 grams C-V  44-53-250(b)
Not more than 2.5 milligrams of diphenoxylate and not less than 25 micrograms of atropine sulfate per dosage unit; C-V  44-53-250(b)
Not more than one-half milligram of difenoxin and not less than twenty-five micrograms of atropine sulfate per dosage unit. C-V  44-53-250(b)

 

Reporting of Xylazine-Positive Laboratory Results 

Overview - Drug Control 

Controlled Substance Schedule 

Past Board Orders 

New Registrations 

Renewals 

Cancellations 

Changes - Name, Address, Drug Schedules 

Annual Inventory Controlled Substance Verification 

Drug Destruction, Theft, Loss 

Prescription Monitoring Program - SCRIPTS 

Related Topics

Drug Control Laws Effective as of January 1, 2021

Authorization for Emergency Dispensing

2017-2018 Drug Control Laws

Tags
drug control